3D illustration of dna sequencing method
DNA-Sequenzierung (Illustration)

Image source: Shutterstock/ktsdesign

News • Cancer therapy

Chemo after breast cancer surgery? Gene expression test to help decision

Following surgery, patients with breast cancer are faced with the question of whether additional chemotherapy is necessary and really effective. It is important that these women do not receive too much treatment – but not too little treatment either.

Physicists from Leipzig University modelled the gene expression tests and examined their usefulness on the basis of these models. Professor Josef Käs from Leipzig University led these investigations in collaboration with the head of the Institute of Pathology Hamburg-West, Professor Axel Niendorf, and the independent statistical consultant Bernhard Ulm. They have just published their findings in PLOS ONE, a multidisciplinary journal that pays particular attention to whether experiments and data analyses have been conducted rigorously.

These tests are based on gene lists and make mistakes at different points, so to speak. This could be exploited by combining several tests and thus increasing the probability of finding the patients who definitely will not benefit from chemotherapy.

Josef Käs

Gene expression tests examine how active certain genes are in tumour cells. Often, these genes are related to characteristic features of cancer, such as tumour growth or invasion of surrounding tissue by tumour cells. A gene expression test therefore represents a method of quantifying the activities of several genes, i.e. a gene list, and thus calculating the probability of whether and when the patient will develop metastases. The results of these studies show, on the one hand, the limits of the certainty of the predictions achieved with such gene lists and further indicate that the examination of different combinations of gene lists does not differ significantly in terms of outcome. Interestingly, the researchers have shown that even random genes can be prognostic: that means even those genes that seem unrelated to the characteristic features of cancer. Here, using a classical statistical analysis and a new approach in machine learning, the physicists showed that such gene lists are in fact prognostic in a sufficiently large collective and show high correspondences between prognosis and the actual course of the disease. 

Contrary to the common recommendation in clinical practice to perform only one test, these gene lists showed that the certainty regarding a chemotherapy recommendation is much higher if more than one test is performed. “The fact that the tests are very successful in a collective and tend to be less successful on the individual patient seems at first to be a contradiction,” said Professor Käs, “but these tests are based on gene lists and make mistakes at different points, so to speak. This could be exploited by combining several tests and thus increasing the probability of finding the patients who definitely will not benefit from chemotherapy.” 

With ongoing debates about whether gene expression tests are useful, this is an important contribution to the decision-making process and will have great impact in terms of how clinicians use such tools. For individual patients in particular, these results imply that circumspection is required in the use of gene expression tests. A limitation from a methodological point of view is that the researchers did not perform commercially available tests; the analyses are based on gene expression values recorded in public breast cancer databases. 


Source: Leipzig University

14.02.2022

Read all latest stories

Related articles

Photo

News • Mammacarcinoma study

Breast cancer: finishing treatment soon after diagnosis increases survival

Research from Cleveland Clinic in the U.S. and Cleveland Clinic Abu Dhabi in the U.A.E. has found a decrease in patient survival rates when treatment options – surgery, chemotherapy and radiation…

Photo

News • Relapse rate research

Breast cancer: Fertility preservation measures do not increase recurrence risk

A new study shows that women with a breast cancer diagnosis undergoing procedures for fertility preservation are not at increased risk of recurrence of the disease or disease-specific mortality.

Photo

News • Companion treatment

Magnetic therapy to enhance breast cancer chemotherapy

A team of researchers from Singapore has developed a novel magnetic therapy that serves as an effective companion therapy to chemotherapy to enhance treatment outcome for breast cancer.

Related products

AB-CT – Advanced Breast-CT – nu:view

Mammo CT

AB-CT – Advanced Breast-CT – nu:view

AB-CT – Advanced Breast-CT GmbH
Canon Electron Tubes & Devices – X-ray Image Intensifier

Accessories / Complementary Systems

Canon Electron Tubes & Devices – X-ray Image Intensifier

Canon Electron Tubes & Devices Co., Ltd
CliniSys – Genetics Laboratory

LIS / Middleware / POCT

CliniSys – Genetics Laboratory

CliniSys | MIPS Deutschland GmbH
CliniSys | MIPS – MIPS GLIMS genetics

LIS, Middleware, POCT

CliniSys | MIPS – MIPS GLIMS genetics

CliniSys | MIPS Deutschland GmbH
DK Medical – Prostar

Surgical II-C-Arms

DK Medical – Prostar

DK Medical Systems Co., Ltd
Fujifilm – Amulet Bellus II

Mammo Workstations

Fujifilm – Amulet Bellus II

FUJIFILM Europe GmbH
Subscribe to Newsletter